share_log
Moomoo 24/7 ·  Mar 26 10:51
Inozyme Pharma Shares Are Trading Higher After the Company Announced That It Will Discuss Topline Data From Its Ongoing Phase 1/2 Trial of INZ-701 in Adults With ABCC6 Deficiency, and From All Cohorts of Its Ongoing Phase 1/2 Trial of INZ-701 in Adults With ENPP1 Deficiency
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment